Browse all practice questions for the Left Atrial Appendage Occlusion (LAAO) Indications and Interventions Practice Test. Search by topic, open any question and review its full explanation, then test yourself in the practice quiz.

Left Atrial Appendage Occlusion (LAAO) Indications and Interventions Practice Test course image
More practice questions

These questions are part of the practice quiz. Start practicing

  • What is the significance of a new concomitant code in relation to LAAO procedures?
  • What specific measurements are taken to assess LAA morphology?
  • Which of the following is NOT typically a focus of patient education before LAAO?
  • What is a contraindication to anticoagulation therapy?
  • What is the mechanism by which LAAO devices prevent stroke?
  • What are the release criteria for the Watchman FLX PASS device?
  • What aspect of anticoagulation management is a consideration for patients undergoing LAAO?
  • What type of catheter is typically used for device placement during LAAO?
  • What is the minimum number of transseptal procedures required for a surgeon to be certified to perform LAAO?
  • What does the HAS-BLED score evaluate?
  • What quadrants should be used for measuring the left atrial appendage (LAA) during transesophageal echocardiography (TEE)?
  • How can the effectiveness of LAAO be evaluated?
  • What does a CHA2DS2-VASc score of 2 or higher indicate?
  • Why is the orientation of the device important when deploying the LAAO device?
  • How is LAAO typically assessed after the procedure?
  • What parameters were studied in the Watchman FLX trial?
  • How should the diameter of the left atrial appendage be determined during measurements?
  • Why is the left atrial appendage important in atrial fibrillation?
  • What is the primary function of Vitamin K in blood clotting?
  • What initial assessment does the device undergo related to its stability?
  • What anatomical considerations are critical for selecting LAAO devices?
  • In the context of LAAO, what does CHA2DS2-VASc >/= 3 indicate?
  • What is essential for optimal sealing during the LAAO procedure?
  • Post-operative management for patients who have undergone LAAO typically requires what?
  • What is the role of the heart team's multidisciplinary approach in LAAO?
  • What does lobe compression refer to in the context of Amulet device release criteria?
  • What should patients expect during recovery after LAAO?
  • What should be excluded during a pre-procedural assessment for LAAO?
  • Which cardiovascular risk factors are commonly associated with atrial fibrillation?
  • What does successful lobe separation imply for the performance of the Amulet LAAO device?
  • Patients undergoing LAAO procedures are primarily at risk for stroke due to what factor?
  • How does LAAO impact the quality of life in patients with atrial fibrillation?
  • In the context of atrial fibrillation, what does increased left atrial pressure indicate?
  • What aspect of the Amulet device helps facilitate its function in the LAAO procedure?
  • What aspect of patient care is critical before proceeding with LAAO?
  • What key education points should be included for patients prior to LAAO?
  • Which of the following devices is identified as an LAAO device?
  • What is the Watchman FLX?
  • How long is the half-life of Warfarin, and what does this imply for procedures?
  • How much should the device be compressed to meet the size pass criteria?
  • Which of the following is NOT a factor in the CHA2DS2-VASc score?
  • What is a major benefit of using the Watchman device in LAAO procedures?
  • Which of the following statements is true regarding the Amulet and Watchman devices?
  • What type of procedure is associated with Surgical LAAO?
  • Which views are important for taking left atrial appendage measurements using TEE?
  • What potential impact does active infection have on LAAO candidacy?
  • What aspect of valvular anatomy is assessed using CT imaging?
  • How is an interatrial septal aneurysm typically visualized in transthoracic echocardiography (TTE)?
  • Which of the following interventions is generally NOT indicated for a patient after LAAO?
  • What describes the 'chicken wing' LAA shape?
  • What does the CLOSE criterion related to separation between device lobe and disc ensure?
  • Which scoring system must be at least 3 for a patient to be eligible for LAAO?
  • Which clinical condition is essential for CMS to provide coverage for Watchman FLX?
  • What shape is described for the disc in the CLOSE criteria?
  • What should be closely monitored after an LAAO procedure?
  • What is the function of follow-up echocardiograms after undergoing LAAO?
  • During which phase of the cardiac cycle is ECG Gating CT triggered to capture images?
  • What laboratory test is commonly used to monitor the therapeutic window of Warfarin?
  • For LAAO eligibility, what is the significance of having a CHADS2 score greater than 2?
  • What is one of the specific measurements needed when assessing LAA dimensions?
  • What is typically required if a pericardial effusion compresses the heart?
  • How can chronic atrial fibrillation affect the success of LAAO procedures?
  • Which patient population is primarily considered for LAAO procedures?
  • What is the primary purpose of a Left Atrial Appendage Occlusion (LAAO) device?
  • Which type of sedation might be used during LAAO procedures?
  • What is a common requirement for successful LAAO patient education?
  • Which imaging technique is useful for assessing the posterior view for TSP during LAAO?
  • What position should the TEE transducer be closest to during LAA procedures?
  • Which of the following is an example of a Direct Acting Oral Anticoagulant (DOAC)?
  • Why are definitions of non-valvular atrial fibrillation important for LAAO eligibility?
  • What is the normal INR range for a healthy individual?
  • When educating patients about LAAO complications, what is a crucial topic to discuss?
  • Who is qualified to perform Left Atrial Appendage Occlusion (LAAO) procedures?
  • What is the average size range of the left atrial appendage in adults?
  • What is the long-term goal of LAAO?
  • Which characteristic is relevant to the assessment of LAA morphology?
  • What is the primary indication for Left Atrial Appendage Occlusion (LAAO)?
  • What does Warfarin do to the body's ability to utilize Vitamin K?
  • How does LAAO influence the management of paroxysmal atrial fibrillation compared to persistent atrial fibrillation?
  • Which of the following is a long-term complication associated with LAAO?
  • Which devices are commonly used for LAAO?
  • Which clinical trials are known for evaluating the effectiveness of LAAO?
  • Which trial compared the effectiveness of Watchman versus warfarin for stroke risk reduction?
  • What lifestyle changes are recommended after an LAAO procedure?
  • What aspect of atrial fibrillation management is directly influenced by LAAO?
  • What is a potential consequence of consuming a high amount of Vitamin K while on a Vitamin K antagonist?
  • What vital aspects are measured in LAA using TEE?
  • Which patient population is most likely to benefit from LAAO procedures?
  • What is the recommended duration of anticoagulation therapy after LAAO in most cases?
  • What is a major clinical benefit observed in trials assessing LAAO?
  • What role does fluoroscopy play during LAAO procedures?
  • What should be monitored post-LAAO intervention?
  • What is a characteristic of DOACs compared to traditional anticoagulants?
  • What visual aid can be particularly helpful when visualizing Watchman placement?
  • What is a significant characteristic of the left atrial appendage in patients with atrial fibrillation?
  • Which measurement point is critical for evaluating the left atrial appendage using TEE?
  • What are the imaging steps prior to LAAO intervention?
  • What is the role of anticoagulation therapy in patients undergoing LAAO?
  • What characteristic of a catheter aids in stability during LAAO delivery systems?
  • How should LAAO device selection be approached in relation to patient anatomy?
  • What type of LAA shape has the highest association with stroke risk?
  • What is the average procedural success rate for LAAO?
  • What is a distinctive feature of the Amulet LAAO device?
  • Post-procedure, what diagnostic tool is frequently used to assess LAAO?
  • What does the Watchman FLX clinical trial compare?
  • What patient-specific characteristics should be assessed before proceeding with LAAO?
  • What should device placement align with during LAA occlusion procedures?
  • What complication is particularly associated with the use of LAAO devices?
  • What benefit does LAAO provide when compared to long-term anticoagulation use?
  • Which iatrogenic complications can arise from LAAO?
  • What are patients deemed suitable for when considering the Watchman FLX procedure?
  • What is a primary indication for patients to undergo Watchman FLX treatment?
  • What does DRT stand for in the context of LAAO?
  • Which medication class requires dietary monitoring, particularly for leafy greens?
  • Which factors are included in CHA2DS2-VASc scoring?
  • Which aspect does NOT typically factor into the evaluation of LAAO effectiveness?
  • What complication is associated with a swan-shaped LAA?
  • Why is patient education essential prior to undergoing LAAO?
  • What age must a patient be to be considered for LAAO?
  • What defines the PASS position for the device in LAAO?
  • What is a significant risk factor that may lead to the consideration of LAAO?
  • What role does hypertension play in atrial fibrillation?
  • What is a contraindication for LAAO?
  • What should be the INR range for a patient on Warfarin?
  • What is a common post-surgical concern for patients undergoing Surgical LAAO?
  • How does LAAO impact the management of anticoagulation therapy?
  • What are some potential long-term complications after LAAO?
  • Which types of patients are typically ineligible for LAAO?
  • What factor primarily determines the need for LAAO in certain patients?
  • Can LAAO lead to the complete elimination of anticoagulation therapy?
  • What structural heart condition is associated with rheumatic atrial fibrillation?
  • Which factor is considered an additional contraindication to anticoagulation?
  • What is one of the goals of intra-procedural imaging during LAAO?
  • What is an expected requirement for an LAAO device to pass deployment tests?
  • How does the LAAO procedure differ from traditional cardiac surgeries?
  • Where do clinicians aim for transseptal access during LAAO placement?
  • What does CHADS2 score assess for?
  • What is a potential consequence of performing a transseptal puncture through a patent foramen ovale (PFO)?
  • Which of the following is true about a double transseptal puncture (TSP)?
  • Why is it necessary to monitor patients on Vitamin K antagonists closely?
  • What is the appearance of a thrombus on echocardiography in the left atrial appendage?
  • What should be the overall characteristic of the device after passing the seal test?
  • Which LAA shape resembles a swimming bird and is more complicated due to its bends?
  • What is the expected time frame for LAAO device integration within the tissue?
  • What was a significant finding from the Protect AF trial?
  • During follow-up, what is crucial for patients who have undergone LAAO?
  • What class of medications is commonly prescribed to patients with atrial fibrillation for stroke prevention?
  • What role do patients have in their post-LAAO care?
  • Which structure is the ICE transducer closest to when placed?
  • What is essential follow-up care after LAAO?
  • What criterion indicates that the device lobe is adequately positioned relative to the LCx coronary artery?
  • What is a common post-procedure complication that requires monitoring in LAAO patients?
  • What primary advantage does the ICE transducer provide during the LAAO procedure?
  • In the context of LAAO, what does the PASS Seal requirement ensure?
  • Why is patient education important regarding LAAO?
  • Which anticoagulant is considered a Vitamin K antagonist?
  • Why is the follow-up monitoring essential after LAAO?
  • How does structural heart disease affect candidacy for LAAO?
  • Which condition is NOT included in the HAS-BLED score?
  • What is the primary benefit of LAAO compared to anticoagulation therapy?
  • When is the optimal time to image the Left Atrial Appendage (LAA) using CT?
  • What are CAP and CAP2 studies focused on?
  • What characterizes a single transseptal puncture (TSP)?
  • What is the primary purpose of performing a pre-procedural CT for LAAO?
  • What is a primary patient management step following LAAO?
  • In what clinical scenario is LAAO clearly indicated?
  • What does the presence of severe renal failure indicate regarding anticoagulation therapy?
  • What scoring system is commonly used to assess stroke risk in patients with atrial fibrillation?
  • Which clinical guideline provides recommendations for LAAO procedures in atrial fibrillation?
  • What hemodynamic changes may occur during LAAO?
  • How might the type of atrial fibrillation affect LAAO interventions?
  • In relation to TSP, what risk is increased with a second puncture?
  • What is the significance of left atrial enlargement in patients with atrial fibrillation?
  • What are the primary complications associated with LAAO procedures?
  • What is required for a device to pass the stability criteria during assessment?
  • What factor influences the decision to discontinue anticoagulation therapy after LAAO?
  • What information should be emphasized during patient education regarding LAAO?
  • In which setting is LAAO typically performed?
  • What is a key Medicare indication for LAAO?
  • Which view is recommended for evaluating the 3D geometry of the LAA during TEE?
  • Which imaging modality is typically used to assess the anatomy of the left atrial appendage before LAAO?
  • How is the size of the device selected for LAAO?
  • What is an expected outcome of successful LAAO in patients with atrial fibrillation?
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy